Predicting and diagnosing spasticity after acute stroke
Official title: Changing Practice: Prognosis and Diagnosis of Spasticity in Acute-post Stroke Patients: a Pilot Study
Run by McGill University · NCT05179473 · Data updated 2026-11-12
We will test whether a new neurophysiological measure (TSRT and its velocity sensitivity, mu) can detect and track developing spasticity during the first three months after an acute middle cerebral artery stroke in people with arm or leg weakness.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | McGill University Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | June 17, 2021 |
| Main results expected | December 30, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | June 4, 2025 |
| Trial ID | NCT05179473 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a recent acute ischemic or hemorrhagic stroke in the middle cerebral artery territory causing hemiparesis, who are medically stable and able to give informed consent, are the intended participants.
✕Probably not a fit
Patients with severe cognitive disorders or ataxia, chronic stroke beyond the early post-stroke period, or strokes outside the MCA territory are unlikely to benefit from or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational follow-up of patients with acute middle cerebral artery (MCA) strokes who develop hemiparesis, tracking spasticity over the first three months. Investigators will use a new neurophysiological measure (tonic stretch reflex threshold angle, TSRT, and its velocity sensitivity mu) alongside common clinical tests such as the Modified Ashworth Scale to compare timing and severity of spasticity. Detailed brain imaging will be performed to relate lesion location and extent to later spasticity development. The primary goal is to describe the natural history of post-stroke spasticity and determine whether TSRT/mu provides earlier or more objective detection than routine clinical measures.
Why it matters
Potential benefit: If successful, this could enable earlier, more objective detection of post-stroke spasticity and guide timely rehabilitation or treatments to reduce long-term disability.
How similar studies have gone: Routine clinical scales like the Modified Ashworth Scale are widely used but limited, and using TSRT and mu is relatively novel though prior neurophysiological work suggests potential value.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute stroke in Middle Cerebral Artery area resulting in hemiparesis. * Hemorrhagic or ischemic * Medically stable * Able to provide informed consent Exclusion Criteria: * Severe cognitive disorders * Ataxia
Where it's running
-
Jewish General Hospital
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Theodore Wein, MD — Montreal Neurological Institute
- Study coordinator: Mindy F. Levin, PT, PhD
- Email: mindy.levin@mcgill.ca
- Phone: 450-688-9550
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effectiveness of a new neurorehabilitation technology for stroke recovery
This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.
-
Emergency Stroke Unit for treating acute strokes
This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.
-
Using the Atalante exoskeleton to help stroke patients walk again
This study is testing if using the Atalante exoskeleton can help stroke patients walk better compared to regular therapy.
-
Collecting data from patients admitted to the Stroke unit
This study is collecting health information from patients in the Stroke unit to help improve future stroke care and research.
-
HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke
We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.
-
Tenecteplase versus alteplase before mechanical thrombectomy for acute large-vessel ischemic stroke
This trial tests whether tenecteplase given before mechanical thrombectomy helps adults with acute large-vessel ischemic stroke within 4.5 hours recover better than standard alteplase.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.